These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15765617)

  • 1. The role of thiazolidinediones in the treatment of patients with type 2 diabetes mellitus.
    Mooradian AD; Chehade J; Thurman JE
    Treat Endocrinol; 2002; 1(1):13-20. PubMed ID: 15765617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione derivatives in type 2 diabetes mellitus.
    Tack CJ; Smits P
    Neth J Med; 2006 Jun; 64(6):166-74. PubMed ID: 16788214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes.
    Cox SL
    Drugs Today (Barc); 2004 Jul; 40(7):633-43. PubMed ID: 15510236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
    Lebovitz HE; Kreider M; Freed MI
    Diabetes Care; 2002 May; 25(5):815-21. PubMed ID: 11978674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and pioglitazone: Effectively treating insulin resistance.
    Staels B
    Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation.
    Czoski-Murray C; Warren E; Chilcott J; Beverley C; Psyllaki MA; Cowan J
    Health Technol Assess; 2004 Apr; 8(13):iii, ix-x, 1-91. PubMed ID: 15038907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U; Pop-Busui R; Eagle KA
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can thiazolidinediones delay disease progression in type 2 diabetes?
    Leiter LA
    Curr Med Res Opin; 2006 Jun; 22(6):1193-201. PubMed ID: 16846552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability.
    Vasudevan AR; Balasubramanyam A
    Diabetes Technol Ther; 2004 Dec; 6(6):850-63. PubMed ID: 15684639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.
    Walter H; Lübben G
    Drugs; 2005; 65(1):1-13. PubMed ID: 15610048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.
    Smiley D; Umpierrez G
    Expert Opin Pharmacother; 2007 Jun; 8(9):1353-64. PubMed ID: 17563269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand.
    Chirakup S; Chaiyakunapruk N; Chaikledkeaw U; Pongcharoensuk P; Ongphiphadhanakul B; Roze S; Valentine WJ; Palmer AJ
    Value Health; 2008 Mar; 11 Suppl 1():S43-51. PubMed ID: 18387067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.
    Home PD; Pocock SJ; Beck-Nielsen H; Gomis R; Hanefeld M; Dargie H; Komajda M; Gubb J; Biswas N; Jones NP
    Diabetologia; 2005 Sep; 48(9):1726-35. PubMed ID: 16025252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "glitazones": rosiglitazone and pioglitazone.
    Papoushek C
    J Obstet Gynaecol Can; 2003 Oct; 25(10):853-7. PubMed ID: 14532954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
    Consoli A; Formoso G
    Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.
    Braunstein S
    Clin Ther; 2003 Jul; 25(7):1895-917. PubMed ID: 12946541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.